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Nodal, a member of the TGF-β family of signaling molecules, has been implicated in pluripotency in human embryonic stem cells (hESCs)
[Vallier, L., Reynolds, D., Pedersen, R.A., 2004a. Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default
pathway. Dev. Biol. 275, 403–421], a finding that seems paradoxical given Nodal's central role in mesoderm/endoderm specification during
gastrulation. In this study, we sought to clarify the role of Nodal signaling during hESC differentiation by constitutive overexpression of the
endogenous Nodal inhibitors Lefty2 (Lefty) and truncated Cerberus (Cerb-S) and by pharmacological interference using the Nodal receptor
antagonist SB431542. Compared to wildtype (WT) controls, embryoid bodies (EBs) derived from either Lefty or Cerb-S overexpressing hESCs
showed increased expression of neuroectoderm markers Sox1, Sox3, and Nestin. Conversely, they were negative for a definitive endoderm marker
(Sox17) and did not generate beating cardiomyocyte structures in conditions that allowed mesendoderm differentiation from WT hESCs. EBs
derived from either Lefty or Cerb-S expressing hESCs also contained a greater abundance of neural rosette structures as compared to controls.
Differentiating EBs derived from Lefty expressing hESCs generated a dense network of β-tubulin III positive neurites, and when Lefty expressing
hESCs were grown as a monolayer and allowed to differentiate, they generated significantly higher numbers of β-tubulin positive neurons as
compared to wildtype hESCs. SB431542 treatments reproduced the neuralising effects of Lefty overexpression in hESCs. These results show that
inhibition of Nodal signaling promotes neuronal specification, indicating a role for this pathway in controlling early neural development of
pluripotent cells.
© 2007 Elsevier Inc. All rights reserved.Keywords: Human embryonic stem cells; Lefty; Nodal; Activin; Neuroectoderm; NeuronsIntroduction
Embryonic stem cells (ESCs) derive their pluripotency from
their embryonic origin in the inner cell mass of blastocysts
(Evans and Kaufman, 1981; Thomson et al., 1998). They are
unique among mammalian cells in being able to grow
indefinitely in vitro while maintaining a capacity to differentiate
into all adult cell types. Interestingly, recent studies have shown⁎ Corresponding author. Department of Surgery, University of Cambridge,
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doi:10.1016/j.ydbio.2007.10.003that mouse ESCs (mESCs) and human ESCs (hESCs) maintain
their pluripotent status using different signaling pathways. LIF
signaling is essential for mESC self-renewal (Nichols et al.,
1990; Yoshida et al., 1994), but it is not active in hESCs
(Daheron et al., 2004; Humphrey et al., 2004). Instead, Activin/
Nodal signaling is essential for the maintenance of hESC
pluripotency and self-renewal, with FGF-2 acting as a
competence factor (Vallier et al., 2004a, 2005; James et al.,
2005; Beattie et al., 2005; Xiao et al., 2006).
Activin and Nodal, members of the TGF-β superfamily, are
also responsible for inducing mesendoderm, the precursor of the
definitive mesodermal and endodermal lineages during gas-
trulation (reviewed in Schier, 2003). Nodal signaling is
regulated by Cripto, an extracellular GPI-linked protein that
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including Lefty1, Lefty2 and Cerberus, are capable of
modulating early vertebrate development (Perea-Gomez et al.,
2002; Meno et al., 1999; Belo et al., 1997). Recent evidence
suggests that Lefty2 binds to Cripto and prevents the formation
of the Nodal/Cripto/receptor complex, thereby inhibiting Nodal
signaling (Chen and Shen, 2004; Cheng et al., 2004). A
truncated form of Cerberus, Cerb-S, has been found to block
Nodal specifically by direct binding to the ligand (Piccolo et al.,
1999). Lefty expression at peri-implantation stages of mouse
development further suggests an early role for it in anterior–
posterior patterning in the mouse embryo (Takaoka et al., 2006).
In each of these cases the probable mechanism of inhibitor
action is the disruption of signaling through the Activin/Nodal
pathway.
Although numerous studies have shown the importance of
diminished BMP signaling for neural induction during
vertebrate development (reviewed in Munoz-Sanjuan and
Brivanlou, 2002), less is known about the role of other
members of the TGFβ superfamily. Nodal−/− embryos show
enhanced neuroectoderm differentiation (Camus et al., 2006),
suggesting that Nodal acts as an inhibitor of neuroectoderm
specification in vivo. In addition, Cripto−/− mESCs show a
propensity for neuronal differentiation (Liguori et al., 2003;
Sonntag et al., 2005). Furthermore, recent studies suggest a
role of Nodal inhibition in neural induction in mouse and
human ESCs in vitro (Vallier et al., 2004a; Watanabe et al.,
2005). Lefty expression has also been characterised in hESCs
during their differentiation and has been implicated in
ectoderm specification (Dvash et al., 2007). Thus, Nodal
signaling not only controls mesendoderm differentiation
during gastrulation, but may also have a reciprocal develop-
mental role in preventing cells from differentiating into
ectodermal or neural fates both in vivo and in vitro.
In this study, we investigated whether the inhibition of
Nodal signaling in hESCs would promote their specification
into neural progenitors in vitro. Nodal inhibition was initially
accomplished by overexpressing full-length Lefty2 (Lefty) or a
truncated form of Cerberus (Cerb-S) in hESCs grown in
Chemically Defined Medium (CDM), where BMP signaling is
quiescent (Vallier et al., 2005). We found that overexpression
of either Lefty or Cerb-S resulted in a pronounced increase in
neuroectoderm development. Furthermore, similar effects
could be achieved with the specific pharmacological inhibitor
of type I Activin/Nodal receptor signaling, SB431542. These
data strongly support the hypothesis that Nodal signaling
inhibits neuroectoderm specification during early hESC
differentiation (Vallier et al., 2004a; Sonntag et al., 2005;
Camus et al., 2006), and provide a robust means of achieving
neural differentiation from hESCs.Materials and methods
Human embryonic stem cell culture
H9 (WiCell Inc., Madison, Wisconsin, USA) and hSF-6 (UCSF, San
Francisco CA, USA) hESCs were routinely cultured as described (Schattenet al., 2005) in KSR medium containing KO-DMEM supplemented with Serum
Replacement (Invitrogen), glutamate (1 mM) and β-mercaptoethanol (0.1 mM).
Every 4 days, cells were harvested using 1 mg/ml collagenase IV (Gibco) and
then plated into 60 mm plates (Costar) pre-coated with 0.1% porcine gelatin
(Sigma) and containing irradiated mouse embryonic fibroblasts. For serum
replacer-free culture, hESCs were grown in Chemically Defined Medium
(CDM) (Johansson and Wiles, 1995), supplemented with Activin (10 ng/ml,
R&D systems) and FGF2 (12 ng/ml, R&D systems). The composition of CDM
was 50% IMDM (Gibco) plus 50% F12 NUT-MIX (Gibco), supplemented with
7 μg/ml of insulin (Roche), 15 μg/ml of transferrin (Roche), 450 μM of
monothioglycerol (Sigma) and 5 mg/ml bovine serum albumin fraction V
(Sigma). To enable hESCs to adhere in CDM, plates were pre-coated with foetal
bovine serum (FBS)(Hyclone) or Fibronectin 10 μg/ml (Chemicon) for 24 h at
37 °C and then washed twice in PBS.
Karyotypic analyses were performed on H9 and hSF-6 cells at various
passages. Abnormalities involving chromosomes 9, 5, and 19 were occasionally
observed at late passages (p80–p115) confirming that hESCs can incur genetic
alterations under certain conditions (Draper et al., 2004). Consequently only
hESCs from earlier passages (p50–p70) were used for these experiments.
Generation of expression constructs and stable transfection
Plasmid pTP6 (Pratt et al., 2000) containing the CAGG (hCMV/Chicken
β-Actin chimeric promoter) driving the expression of GFP-IRES-Puromycin,
was used as the basis for constructing Lefty and Cerb-S expression vectors.
pTP6 was digested with EcoR1, removing the GFP open reading frame
(ORF), and either mouse Lefty2 or Xenopus Cerb-S ORFs were cloned into
this site to generate pTP6-Lefty2 and pTP6-Cerb-S respectively. For stable
expression with vectors encoding Lefty2 or Cerb-S, 3 confluent 60 mm
plates containing around 2000 hESC colonies each were plated onto one 6
well gelatin-coated plate containing mouse feeders. After 48 h the cells were
transfected using Lipofectamine 2000 (Invitrogen) as described (Vallier et al.,
2004b). Three days after transfection, the cells were passaged onto 60 mm
gelatin-coated tissue-culture plates containing puromycin-resistant mouse
feeders. After 3 additional days, puromycin (1 μg/ml final concentration)
was added. Puromycin-resistant colonies that appeared by 12 days of
selection were picked, dissociated and plated onto 24-well gelatin-coated,
feeder containing plates and expanded for further analysis as described
above.
Differentiation of hESCs as EBs
Lefty or Cerb-S expressing hESCs (as well as wildtype H9 and hSF-6
hESCs) were grown in 6 cm dishes (Corning), on mouse feeders. When
confluent, hESCs were passaged using collagenase 1 mg/ml, as previously
described (Schatten et al., 2005) and cultured in non-adherent conditions in
CDM supplemented with either SU5402 (Calbiochem; 10 μM) or SB431542
(Tocris; 20 μM). Alternatively, hESCs were incubated in DMEM supple-
mented with 10% FCS and 1 mM glutamine (MEF medium) to promote
mesoderm formation. EBs were then grown for 12–16 days at 37 °C at 5%
CO2 before being harvested for histological or molecular marker analysis.
For some experiments, EBs grown in CDM were plated directly on
fibronectin.
Differentiation of hESCs as a monolayer
Wildtype and Lefty expressing hESCs were grown on fibronectin in
FGF(12 ng/ml)/Activin (20 ng/ml) as previously described as a monolayer
in the absence of a feeder layer (Vallier et al., 2005). When cells were 70–
80% confluent medium was changed to either CDM only, CDM/FGF
(12 ng/ml), CDM/Noggin 200 ng/ml, CDM/SU5402 and differentiated for
24 days.
RT-PCR and real-time PCR
Total RNA was extracted from EBs using the Qiagen RNeasy Micro kit
according to manufacturer instructions. For RT-PCR, 50–100 ng of RNA were
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manufacturer instructions. For real-time PCR, 1 μg RNA was reverse-
transcribed using the Qiagen QuantiTect Reverse Transcription kit. 1/20–1/40
of each cDNA reaction was used for each real-time PCR reaction using the
QuantiTect SYBR Green PCR Kit (Qiagen) according to manufacturer
instructions. Relative quantification of gene expression was done by normal-
ising the detected levels of gene of interest mRNA to those of the house-
keeping GAPDH gene. All primers were purchased from Qiagen, with the
exception of Xenopus Cerb-S: Forward 5′-CTGTGACAGGATGGTGATAC-
3′; Reverse 5′-ATGGTGCAGGGTAG TAGATG-3′. Mouse Lefty2: Forward
5′-GGAGATGTACCTGGACCTGC-3′; Reverse 5′-CATCTGAGGCGCAGC-
TACAG-3′.
In situ hybridisation
EBs were fixed in 4%PFA in PBS at 4 °C o/n, and stored in methanol at
−20 °C. In situ hybridisation was performed as described previously (Harland,
1991), with slight modifications.
Immunocytochemistry
Immunocytochemistry for pluripotency markers Oct4 and Tra-1-60 has been
described previously (Vallier et al., 2004b). Immunocytochemistry was
performed for the pluripotency marker Oct4 (Santa-Cruz) and the differentiation
markers Sox17 (R&D systems), Sox1 (kind gift of Dr. Robin Lovell-Badge),
Nestin (Abcam), β-tubulinIII (Chemicon), Neurofilament (Sigma), GABA
(Sigma), glutamate (Sigma). Cells were fixed with 4% paraformalyhyde for
15 min and blocked with 10% fetal calf serum/0.01% Triton X-100 for 1 h.
Primary antibodies were incubated at 4 °C for 16 h in 1% fetal calf serum/0.01%
Triton X-100. Cells were washed repeatedly and incubated with appropriate
fluorescent secondary antibodies (Jackson laboratories) for 4 h. For cell
counting studies, random fields were observed and the number of positive cells
averaged over 10 fields.
Southern blot analysis
Genomic DNA was isolated from hESCs using QIAGEN Genomic-Tip
100/G according to the manufacturers' instructions. 10 mg of genomic DNA
was digested with Xba1 (60 units) for 16 h Southern blot and hybridisation
and using [P32]dCTP labelled probe has been described previously
(Sambrook et al., 2001). Probe used corresponds to the first 600 bp of the
CAG promoter.Fig. 1. (A) Southern blot analysis using a 600 bp fragment of the CAG promoter as a
expressing hESC clones. (B) RT-PCR analysis of Lefty and Cerb-S expressing human
xenopus Cerb-S expression from stable single copy integration clones. (C) Immu
expression of pluripotency markers Oct-4 (Red) and TRA-1-60 (Green) (Scale bar=Results
Characterisation of Lefty and Cerb-S expressing hESCs
Human ESCs grown in non-adherent conditions aggregate to
form embryoid bodies (EBs) in which differentiation is initiated
along both extra-embryonic and primary embryonic germ layer
pathways (Vallier et al., 2004a). We used this model to study
mechanisms controlling neuroectoderm specification of hESCs,
as EBs reproduce three-dimensional cellular interactions. To
explore the function of Nodal signaling in these EBs, we stably
over-expressed Lefty2 and Cerb-S in the hESCs from which the
EBs were derived, using the robust expression vector pTP6
(Pratt et al., 2000).
Southern blot analysis using the CMV promoter as a probe
(first 600 bp of CMV/chicken β-Actin chimeric promoter)
showed single copy integration for both Lefty and Cerb-S
overexpressing hESC H9 lines. As expected, wildtype H9
genomic DNA did not hybridise with this probe (Fig. 1A). Only
single copy integrants were used for further study. Stable clones
generated using the Lefty-pTP6 vector (N=18 for H9 cell line
and N=10 for hSF-6 cell line) and the Cerb-S-pTP6 vector
(N=26 for H9 cell line and N=8 for hSF-6 cell line) were
screened for Lefty or Cerb-S expression using RT-PCR. Fig. 1B
shows representative RT-PCR analyses of Lefty and Cerb-S
overexpressing clones. In addition, an hrGFP overexpressing
hESC cell line (Vallier et al., 2004a) was included as a negative
control in RT-PCR analysis along with wild type hESCs to
control for any effects induced by the genetic manipulation
procedure itself (data not shown). The numbers of stably
transfected colonies generated using the Lefty-pTP6 and Cerb-
S-pTP6 vectors were similar to those generated using the
hrGFP-pTP6 vector (data not shown). Three independent
clones for both Lefty and Cerb-S expressing H9 and hSF-6
hESCs were further characterised and used for subsequent
experiments.probe reveals single-copy integration of expression vectors for Lefty and Cerb-S
embryonic stem cells, shows robust, specific expression of either mouse Lefty or
nocytochemistry of Lefty and Cerb-S expressing hESCs shows homogenous
200 μM).
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Lefty or Ceberus expressing hESCs. This was clear from the
ability of supernatants of such cultures to induce differentiation
of EBs derived from Nodal overexpressing hESCs (data not
shown). However, pluripotent Lefty and Cerb-S expressing
hESC lines, like wildtype hESCs, expressed the pluripotency
markers Oct4 and Tra-1-60 (Fig. 1C) during a prolonged period
of culture with feeder cells (30 passages/5 months). These
results demonstrate that inhibition of the endogenously
produced Nodal by either Lefty or Cerb-S expressing clones
did not lead to differentiation of hESCs grown in conditions
supportive of pluripotency. This could reflect the ability of
mouse feeders to secrete sufficient Activin to maintain pluri-
potency under these conditions (Vallier et al., 2005). Further-
more, Lefty expressing hESCs grown in feeder-free conditions
in CDM medium supplemented with Activin/FGF maintained
their expression of pluripotent markers Oct4 and Tra-1-60 (data
not shown) also indicating that Activin can circumvent the
inhibiting effects of Lefty on Nodal Activity.
Lefty or Cerb-S overexpression drives differentiation of hESCs
toward the neuroectodermal pathway at the expense of other
lineages
To investigate the development of EBs derived from Lefty or
Cerb-S overexpressing hESCs, we grew the cells as EBs in
suspension culture using CDM medium. As previously
observed (Vallier et al., 2004a), wildtype control EBs grown
in CDM developed almost exclusively as simple spheres with
no apparent tissue organisation (Fig. 2A). By contrast, the
majority of EBs derived from Lefty overexpressing hESCs
showed a unique phenotype, consisting of epithelial layers
organised into regular folded structures and bearing a striking
resemblance to the neural folds formed during early vertebrate
development (Fig. 2A). Cerb-S expressing EBs showed an
epithelial phenotype similar to Lefty EBs, but with fewer folded
structures (Fig. 2A). Hematoxylin/Eosin staining of sectioned
EBs confirmed that these folded structures found in Lefty
overexpressing EBs were neuroectoderm-like, with internal
epithelial rosettes (Fig. 2B). Lefty and Cerb-S expressing EBs
contained respectively 5 times (Pb0.05) and 2 times (not
significant, N.S.) more epithelial rosettes than control EBs
(Fig. 2C). These results indicate that inhibition of the Activin/
Nodal signaling pathway by Lefty produces a striking alteration
of developmental fate of hESCs.
To test whether the EBs derived from either Lefty or Cerb-S
overexpressing hESCs were neural in character, EBs were fixed,
sectioned and immuno-stained for markers of definitive
neuroectoderm (Nestin and Sox1), endoderm (Sox17) and
mesoderm (Brachyury). Lefty and Cerb-S expressing EBs
grown in CDM showed an overall increase in expression of the
neuroectoderm markers Nestin and Sox1 compared to wildtype
EBs, while there was a concomitant reduction in expression of
the endoderm marker Sox17 in Lefty and Cerb-S expressing
cells when EBs were grown in MEF medium (Fig. 3A), a
condition known to promote mesendoderm specification.
Brachyury expression was observed neither in control EBsnor in Lefty or Cerb-S expressing EBs (data not shown). In situ
hybridisation analysis supported these results, showing that at
14 days EBs derived from Lefty overexpressing hESCs showed
up-regulation of the neuroectoderm markers Nestin and Sox3
and the neuronal differentiation marker Neurogenin2 (NGN2)
(Fig. 3B). In addition, Lefty expressing EBs showed a more
pronounced down-regulation of the pluripotency marker Oct4
as compared to controls (Fig. 3B). Real time qPCR analysis was
employed to quantify these effects. Comparison of the
expression of Nestin, Sox3, Sox1 and NGN2 in four
independent batches of WT and Lefty EBs showed a clear
increase in the mean expression levels of most markers (Pb0.05
for Nestin, Sox3 and Sox1), though the level of NGN2 was not
significantly greater (Student's T-test, P=0.094) (Fig. 3C).
To evaluate further the differentiation potential of Lefty and
Cerb-S overexpressing hESCs, EBs were cultured in MEF
medium containing fetal bovine serum (FBS), which promotes
the formation of mesoderm lineages including cardiomyocytes,
as recognised by rhythmically beating structures. Lefty over-
expressing EBs grown in these conditions displayed a decreased
incidence of rhythmically contracting structures as compared to
wildtype EBs, [∼ 79% decrease for Lefty (Pb0.01), ∼ 53% for
Cerb-S (NS)], suggesting a reduced ability to generate
mesoderm (Fig. 3D). Nodal expressing EBs grown in these
conditions were not seen to generate such beating structures,
and instead maintained expression of the pluripotency marker
Oct-4 (Fig. 3D and data not shown).
To observe the ability of Lefty and Cerb-S expressing EBs to
differentiate into specific neuronal cell types, WT, Lefty or
Cerb-S EBs grown for 12 days as suspension cultures in CDM
were re-plated on fibronectin coated plates in CDM and cultured
in these conditions for 12 more days. EBs derived from Lefty
expressing hESCs (both H9 and hSF-6) showed substantial
neurite outgrowths as compared to Cerb-S and wildtype cells.
This was particularly evident when the cultures were stained
with an antibody to the pan neuronal marker β-tubulin III
(Fig. 4A). Cultures from plated Lefty and Cerb-S EBs were
positive for the neurotransmitters Glutamate and GABA and for
the astrocyte marker glial fibrillary acidic protein (GFAP) (Fig.
4B), confirming that Activin/Nodal inhibition promotes speci-
fication of neural progenitors that are able, under appropriate
conditions, to generate both differentiated neurons and
astrocytes.
To quantify the neurogenic potential of Lefty expressing
hESCs, we cultured Lefty expressing hESCs in feeder-free
conditions as a monolayer in CDM supplemented with Activin
and FGF as described previously (Vallier et al., 2005). When
cells reached 70–80% confluency, medium was changed to
CDM only, CDM plus FGF (12 ng/ml) (CDM/FGF), CDM plus
the BMP inhibitor Noggin (200 ng/ml) (CDM/Noggin) or CDM
plus the FGF receptor inhibitor SU5402 (10 μM) (CDM/
SU5402), and cells were cultured in these conditions for
24 days. Immunostaining for β-tubulin III, a neuronal marker,
revealed abundant neurons generated by Lefty expressing
hESCs, although wildtype hESCs also showed a background
level of neuronal differentiation in these conditions (Fig. 4C).
The incidence of neural differentiation was determined by
Fig. 2. (A) EBs derived from Lefty expressing hESCs form folded epithelial rosette structures (white arrows). (B) Hematoxylin and Eosin stained sections of Wildtype,
Lefty and Cerb-S expressing EBs showing epithelial rosettes (white arrows). (C) Quantitation of rosette structures in EBs of either Lefty or Cerb-S expressing and
wildtype EBs. Lefty expressing EBs had significantly greater numbers of rosette structures as compared to Cerb-S and wildtype (NS=not significant) (Scale
bar=200 μM).
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fields. This showed that when differentiated in CDM, Lefty
expressing hESCs generated more β-tubulin III positive cells/
field (69±13) than wildtype cells, (25±9) (Pb0.01) (Fig. 4D).
FGF signaling was essential for neuronal differentiation in these
conditions, as shown by the effect of the pharmacological
inhibitor SU5402, which induced a significant loss of β-tubulin
III positive cells (Fig. 4E) (Pb0.001). In addition, inhibition of
BMP signaling significantly increased (Pb0.05) the number of
β-tubulin III positive cells, suggesting that BMPs may be
released by differentiating cells in the cultures and restrain
neural cell development. Interestingly, SU5402 treatment of
Lefty expressing hESCs differentiating as EBs generated small
neurospheres-like structures, which strongly expressed β-tubulin III (Fig. 4F). These structures were not observed when
wildtype hESCs were differentiated as EBs in the presence of
SU5402.
Pharmacological inhibition of Nodal signaling in hESCs
mimics Lefty activity in vitro
In view of the complexity of generating transgenic hESC
lines expressing Nodal inhibitors, we also investigated whether
a specific pharmacological inhibitor of Nodal signaling,
SB431542, would also lead to increased neuroectoderm
specification in hESC derived EBs. Comparison of gene
expression by real time qPCR in DMSO- and SB431542-
treated EBs grown in CDM for 14–16 days in the presence of
112 J.R. Smith et al. / Developmental Biology 313 (2008) 107–117SB431542 showed a similar increase in the mean expression
levels of Nestin, Sox3, and NGN2 to that observed in Lefty
expressing EBs (Fig. 5A), though there was not a significant
increase in Sox1 expression levels (Student's T-test; P=0.103).
No substantial changes were observed when comparing
expression of these markers in untreated and DMSO-treatedFig. 3. (A) Immunocytochemistry of Lefty expressing, Cerb-S expressing and wildt
Sox17 and an increase in neuroectoderm markers Nestin and Sox1 in Lefty and Cerb
seen in Lefty EBs was localised to folded epithelial rosette structures (white arrows)
Lefty expressing EBs showed an increase in the expression of neuroectoderm marke
for NGN2 is shown in higher magnification, below. NGN2-positive patches of tissu
robust down-regulation of the pluripotency marker Oct4 (AS, anti-sense). (C) Real tim
and Sox1 expression in Lefty expressing EBs as compared to wildtype. Four indepen
beating structures in Lefty expressing EBs. Lefty, Cerb-S expressing and wildtype
expressing EBs generated fewer beating structures as compared to wildtype EBs (Ncells (data not shown). The addition of Activin to cultures had
the opposite effects of SB431542, namely decreasing expres-
sion of the neuroectoderm markers, Sox1, Sox3, Nestin and
NGN2 (data not shown). We also compared the time course of
hESC differentiation toward neuroectoderm in the presence or
in the absence of SB431542 by harvesting EBs every 4 daysype EBs. Immunostaining of EB sections revealed a loss of mesoderm marker
-S expressing EBs as compared to wildtype EBs. Intensified Nestin staining was
. (B) In situ hybridisation on EBs derived from WT or Lefty expressing hESCs.
rs Nestin and Sox3 and the neural differentiation marker NGN2. The boxed area
e are indicated (black arrowheads). Lefty expressing EBs also showed a more
e qPCR analysis showed significantly increased average levels of Nestin, Sox3
dent batches of WT and Lefty EBs were used for this analysis. (D) Incidence of
EBs were plated in MEF medium, and beating structures were counted. Lefty
S=not significant) (Scale bar=200 μM).
Fig. 3 (continued ).
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PCR. Inhibition of Activin/Nodal signaling by SB431542
caused a rapid down-regulation of the pluripotency marker Oct4
as compared to controls, thus apparently priming the cells for
differentiation (Fig. 5B). By contrast the expression of the
neuroectoderm markers Nestin, Sox3, Sox1 and NGN2
appeared to be upregulated earlier in SB431542-treated EBs
than in control EBs (Fig. 5B). These findings indicate that
forced inhibition of Nodal/Activin signaling results in more
rapid loss of pluripotency and acquisition of neural character by
hESCs compared to spontaneous differentiation, and strongly
support the conclusion that inhibition of Activin/Nodal
signaling, whether by natural or pharmacological inhibitors,
results in highly efficient neuroectoderm specification in vitro
under defined culturing conditions in which BMP signaling is
quiescent.
Discussion
The majority of previous studies attempting to drive either
mouse or human embryonic stem cells along the neuroectoderm
pathway have focused on exposing pluripotent embryonic stem
cells to soluble factors known to induce neurogenesis in thedeveloping mammalian neural tube. Successful protocols
promoting neurogenesis from embryonic stem cells have
utilised sonic hedgehog, FGFs, Noggin, WNTs and retinoic
acid, depending upon the regional specification sought (Reubin-
off et al., 2001; Wichterle et al., 2002; Li et al., 2005; Yan et al.,
2005; Irioka et al., 2005). Other studies have co-cultured hESCs
with specific types of stromal cells to induce neuronal
differentiation (Kawasaki et al., 2002; Perrier et al., 2004).
Although effective, these studies have focused on a develop-
mental time point that is significantly later than when
neuroectoderm is initially specified. By contrast, our findings
address cell fate decisions made early in the process of
neuroectoderm development, which has been studied exten-
sively in experimental embryonic systems. By expressing the
Nodal inhibitors Lefty and Cerb-S in hESCs or using the phar-
macological inhibitor of Activin/Nodal signaling SB431542, we
found that neuroectoderm specification during early develop-
ment of hESCs as EBs depends on the repression of Nodal
signaling.
The default model of neuroectoderm specification is based
on animal cap experiments in Xenopus showing that in the
absence of exogenous growth factors, particularly BMPs,
pluripotent animal cap cells differentiate into neuroectoderm
(reviewed in Munoz-Sanjuan and Brivanlou, 2002). However,
results obtained in the chick embryo demonstrate that
neuroectoderm specification is dependent on FGF signaling.
Accordingly, it was recently proposed that FGF acts first as a
competence factor and then cooperates to inhibit BMP
signaling, thereby blocking the negative effect of BMPs on
neuroectoderm differentiation (Stern, 2005). Moreover, other
findings in Xenopus (Delaune et al., 2005) and in mouse ESCs
are consistent with this recent view (Ying et al., 2003),
suggesting that a neural inductive function of FGF signaling
is conserved through evolution.
While the current models for neuroectoderm specification
are mainly based on the function of FGF and BMP signaling
pathways, much less is known about the involvement of
Activin/Nodal signaling. This pathway is a potent inducer of
mesendoderm differentiation. Since mesendoderm is specified
early in the progression from pluripotency to gastrulation, active
inhibition of this signaling pathway would seem crucial to allow
neuroectoderm specification (Schier, 2003). The absence of
Nodal expression in regions of the mouse embryo giving rise to
neuroectoderm descendants is consistent with this proposed
negative role of Nodal in neural induction (Lawson et al., 1991;
Collignon et al., 1996). Moreover, in chimeric embryos
containing mESCs mutant for Nodal, the ESC progeny
preferentially colonise the anterior region of the embryo,
which gives rise to brain (Lu and Robertson, 2004). Nodal−/−,
Cripto−/− or Smad4−/− embryos all show an increase in
neuroectoderm differentiation, with an absence of mesendo-
derm differentiation (Camus et al., 2006; Sonntag et al., 2005).
These results strongly suggest that loss of Nodal activity is
conducive to normal neuroectoderm specification during early
embryogenesis. We have shown that active inhibition of Nodal
by Lefty, Cerb-S, or the pharmacological Activin/Nodal
inhibitor SB431542 in hESCs all lead to an increase in neuronal
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Fig. 4. (A) Immunocytochemistry for the neuronal marker β-tubulin III on re-
plated wildtype Cerb-S expressing and Lefty expressing EBs. Lefty expressing
EBs appeared to generate denser networks of neurite outgrowths as compared to
Cerb-S expressing and wildtype EBs. (B) Immunocytochemistry for the
neuronal phenotype markers, Glutamate and GABA, and the astrocyte marker
GFAP shows abundant formation of each cell type. (C) Immunocytochemistry
of β-tubulin III positive cells in monolayer culture of either Lefty expressing or
wildtype hESCs. (D) Quantitation of β-tubulin III positive cells in 6 independent
experiments from Lefty expressing and wildtype cells grown as a monolayer
revealed a Lefty induced increase in the number of β-tubulin III positive cells.
(E) Quantitation of β-tubulin III positive cells in 6 independent experiments
from Lefty expressing cells grown in feeder free conditions as a monolayer and
then differentiated in CDMmedium containing either FGF (12 ng/ml), the BMP
inhibitor Noggin (200/ml) or FGF receptor inhibitor SU5402 (20 μM). Lefty
expressing hESCs exposed to FGF did not show a significant increase in the
number of β-tubulin III positive cells as compared to controls, whereas Noggin
produced a significant increase in β-tubulin III positive cells. Interestingly,
inhibition of FGF signalling by SU5402 resulted in a highly significant
reduction in neuron formation as shown by β-tubulin III immunoreactivity. (F)
Immunocytochemistry for β-tubulin III on Lefty or Cerb-S expressing EBs
exposed to SU5402 showed that compact neurospheres were formed when FGF
signalling was inhibited. (NS=not significant) (Scale bar 400 μM).
Fig. 5. (A) Real time qPCR analysis on DMSO- and SB431542 (20 μM)-treated
EBs cultured for 14–16 days. Activin/Nodal inhibition led to a significant
average increase in Nestin, Sox3, and NGN2 expression. Five independent
batches of DMSO- and SB431542-treated EBs were used for this analysis. (B)
RT-PCR on the time course of SB431542 incubation of hESCs reveals a more
rapid downregulation of Oct4 and upregulation of neuroectoderm markers
compared to controls. EBs were treated with DMSO or SB431542 (20 μM) and
analysed by RT-PCR after 4, 8, 12 and 16 days of culture.
115J.R. Smith et al. / Developmental Biology 313 (2008) 107–117differentiation and a concomitant decrease in mesendodermal
differentiation. Therefore, these results confirm that inhibition
of the Activin/Nodal signaling pathway is sufficient for
neuroectoderm differentiation in hESCs when they are grown
in conditions of combined BMP quiescence and FGF activity.
As Nodal is expressed at the late epiblast stage, before the
mesendoderm versus neuroectoderm decision, it is likely that
Nodal plays a key role that is relevant to neural induction.
Collignon and co-workers showed that the epiblast cells of
Nodal−/− embryos lack expression of the pluripotent markers
Nanog and Oct-4, suggesting that Nodal is required to maintain
the pluripotent status of the epiblast layer before gastrulation
and thus before Nodal's role in mesendoderm induction
(Camus et al., 2006). Their observation that the expression of
116 J.R. Smith et al. / Developmental Biology 313 (2008) 107–117pluripotency markers is replaced by the expression of
neuroectoderm markers shows importantly that Nodal is not
simply influencing the decision between mesendoderm and
neuroectoderm, but that it is acting earlier to block neuralisation
in the epiblast. This is consistent with results in hESCs where
Nodal overexpression is sufficient to maintain their pluripotent
status (Vallier et al., 2004a). It is also consistent with our finding
that inhibition of Nodal leads to more rapid and more efficient
neuroectoderm differentiation of hESCs, together with rapid
loss of pluripotency markers (Vallier et al., 2005). Compared to
wild-type hESCs, differentiating cultures of Lefty overexpres-
sing hESCs or hESCs treated with the Activin/Nodal receptor
inhibitor SB431542 express significantly higher levels of early
neuroectoderm markers, including Nestin and Sox3. These
observations suggest that higher numbers of neural precursors
are generated in these conditions. Taken together, these results
demonstrate that Activin/Nodal signaling blocks neuroectoderm
differentiation by maintaining pluripotency of the epiblast layer
in vivo and of hESCs in vitro. We therefore concur with Camus
et al. (2006) that the current model of neuroectoderm
differentiation can be expanded to include inhibition of
Activin/Nodal signaling as a prerequisite for the induction
of neuroectoderm specification during early mammalian
development.
We also determined whether decreased levels of Activin/
Nodal signaling are permissive for further differentiation of
such neuroepithelial progenitors by assaying the expression of
molecular markers known to be up-regulated at later steps along
the neural differentiation pathway. During vertebrate neurogen-
esis, progression of Sox1-positive neural progenitors towards
terminal differentiation involves up-regulation of bHLH
proteins, such as Neurogenin (Kan et al., 2004). Neurogenin2
(NGN2) plays an important role in the progression of neural
precursors (Ma et al., 1996; Nieto et al., 2001; Scardigli et al.,
2001). Our time-course assays using SB431542 indicated that
NGN2 expression increases between 4 and 16 days of EB
differentiation, thus suggesting that neural progenitors gener-
ated through Activin/Nodal inhibition are able to progress along
the neurogenic pathway. As expected, Activin treatment of
differentiating EBs caused opposite effects, maintaining Oct4
expression and repressing the expression of Nestin, Sox1 and
NGN2.
The development of chemically defined and animal
product-free media is a major focus of human stem cell
research. The characterisation of neuronal cells generated by
growing EBs in CDM supplemented with SB431542 is an
important step toward the generation of fully functional cells
for therapeutic use. Indeed, the use of chemically defined
medium avoids the use of other, more complex additives
including animal-derived stroma cells and extracellular
matrix. However, as originally formulated (Johansson and
Wiles, 1995) CDM contains Bovine Serum Albumin (BSA)
whose substitution by human albumin is needed to achieve
culture conditions fully compatible with clinical application.
In sum, Activin/Nodal signaling inhibition provides a unique
in vitro approach to study the mechanisms controlling the first
steps of neuroectoderm development of hESCs. Accordingly,it will permit a better understanding of the molecular mecha-
nisms controlling cell fate specification in early mammalian
development.
Note added in proof
Recent work by Chang et al. (2007) suggests that Neural
induction requires continued suppression of both Smad1 and
Smad2 signals during gastrulation.
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